@article{ATM24223,
author = {Alberto Martini and Reza Mehrazin},
title = {The potential role of germline single nucleotide polymorphisms for selecting the ideal candidates for sunitinib therapy in patients with locally-advanced renal cell carcinoma},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {Renal cell carcinoma (RCC) represents the eighth most common malignant cancer diagnosed in the United States (1). Despite a stage migration of RCC towards a more localized disease over the past decades, a considerable proportion of patients is still diagnosed with loco-regional disease. In case of organ-confined RCC, the overall prognosis for surgically treated patients is fairly good, with a 5-year cancer specific mortality (CSM)-free rate of 91% and for stage I (T1N0M0) and 74% for stage II (T2N0M0).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24223}
}